Higher expression of estrogen response genes in the primary tumor is associated with a greater risk for late recurrence in patients with ER1/HER2-breast cancer

    Research output: Contribution to journalMeeting AbstractAcademic

    Original languageEnglish
    Number of pages1
    JournalAnnals of Oncology
    Volume28
    Publication statusPublished - Sept-2017
    Event42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain
    Duration: 8-Sept-201712-Sept-2017

    Cite this